Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 13.92
(0.72%)
CNY 13.92
(0.72%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.59 Billion CNY | -5.68% |
| 2022 | 1.47 Billion CNY | 37.97% |
| 2021 | 1.06 Billion CNY | 51.46% |
| 2020 | 744.77 Million CNY | 52.31% |
| 2019 | 487.81 Million CNY | 19.65% |
| 2018 | 372.33 Million CNY | 13.16% |
| 2017 | 343.26 Million CNY | 14.7% |
| 2016 | 293.7 Million CNY | -13.57% |
| 2015 | 359.65 Million CNY | 34.19% |
| 2014 | 251.66 Million CNY | -0.87% |
| 2013 | 259.08 Million CNY | 23.71% |
| 2012 | 219.59 Million CNY | 23.93% |
| 2011 | 177.97 Million CNY | 30.76% |
| 2010 | 135.3 Million CNY | 55.37% |
| 2009 | 92.08 Million CNY | 7.95% |
| 2008 | 81.6 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 337.27 Million CNY | -1.66% |
| 2024 Q3 | 193.91 Million CNY | -49.55% |
| 2024 Q1 | 324.36 Million CNY | 98.35% |
| 2023 Q2 | 398.13 Million CNY | -0.58% |
| 2023 FY | - CNY | -5.68% |
| 2023 Q3 | 381.48 Million CNY | -4.18% |
| 2023 Q4 | 151.76 Million CNY | -60.22% |
| 2023 Q1 | 400.46 Million CNY | 83.18% |
| 2022 Q1 | 283.15 Million CNY | 22.73% |
| 2022 FY | - CNY | 37.97% |
| 2022 Q4 | 218.61 Million CNY | -35.77% |
| 2022 Q3 | 340.39 Million CNY | -7.71% |
| 2022 Q2 | 368.83 Million CNY | 30.26% |
| 2021 Q2 | 206.88 Million CNY | 39.7% |
| 2021 FY | - CNY | 51.46% |
| 2021 Q3 | 252.31 Million CNY | 21.96% |
| 2021 Q4 | 230.71 Million CNY | -8.56% |
| 2021 Q1 | 148.09 Million CNY | -28.29% |
| 2020 Q1 | 42.7 Million CNY | -69.14% |
| 2020 Q3 | 101.35 Million CNY | -29.74% |
| 2020 Q4 | 206.5 Million CNY | 103.74% |
| 2020 FY | - CNY | 52.31% |
| 2020 Q2 | 144.25 Million CNY | 237.82% |
| 2019 Q1 | 26.43 Million CNY | -69.41% |
| 2019 FY | - CNY | 19.65% |
| 2019 Q4 | 138.37 Million CNY | 117.78% |
| 2019 Q3 | 63.53 Million CNY | -19.5% |
| 2019 Q2 | 78.92 Million CNY | 198.53% |
| 2018 Q1 | 89.17 Million CNY | 220.43% |
| 2018 FY | - CNY | 13.16% |
| 2018 Q4 | 86.42 Million CNY | 604.87% |
| 2018 Q3 | 12.26 Million CNY | -55.55% |
| 2018 Q2 | 27.58 Million CNY | -69.06% |
| 2017 Q4 | 27.82 Million CNY | -57.27% |
| 2017 Q2 | 43.01 Million CNY | -9.85% |
| 2017 Q1 | 47.7 Million CNY | 31.39% |
| 2017 Q3 | 65.11 Million CNY | 51.4% |
| 2017 FY | - CNY | 14.7% |
| 2016 Q1 | 43.28 Million CNY | -58.32% |
| 2016 FY | - CNY | -13.57% |
| 2016 Q4 | 36.31 Million CNY | -31.9% |
| 2016 Q3 | 53.32 Million CNY | 80.79% |
| 2016 Q2 | 29.49 Million CNY | -31.85% |
| 2015 Q2 | 97.45 Million CNY | 163.22% |
| 2015 Q1 | 37.02 Million CNY | -50.63% |
| 2015 FY | - CNY | 34.19% |
| 2015 Q4 | 103.85 Million CNY | 52.8% |
| 2015 Q3 | 67.96 Million CNY | -30.26% |
| 2014 Q1 | 41.97 Million CNY | -22.5% |
| 2014 FY | - CNY | -0.87% |
| 2014 Q2 | 76.08 Million CNY | 81.27% |
| 2014 Q4 | 74.98 Million CNY | 244.06% |
| 2014 Q3 | 21.79 Million CNY | -71.36% |
| 2013 Q3 | 43.25 Million CNY | 0.0% |
| 2013 FY | - CNY | 23.71% |
| 2013 Q4 | 54.15 Million CNY | 25.22% |
| 2012 FY | - CNY | 23.93% |
| 2011 FY | - CNY | 30.76% |
| 2010 FY | - CNY | 55.37% |
| 2009 FY | - CNY | 7.95% |
| 2008 FY | - CNY | 0.0% |